{
  "actions": [
    {
      "acted_at": "2011-10-13",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2011-10-13",
      "action_code": "",
      "committees": [
        "SSHR"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s1700-112",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Health, Education, Labor, and Pensions",
      "committee_id": "SSHR"
    }
  ],
  "congress": "112",
  "cosponsors": [
    {
      "bioguide_id": "B001267",
      "district": null,
      "name": "Bennet, Michael F.",
      "original_cosponsor": true,
      "sponsored_at": "2011-10-13",
      "state": "CO",
      "title": "Sen.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "B001135",
      "district": null,
      "name": "Burr, Richard",
      "original_cosponsor": true,
      "sponsored_at": "2011-10-13",
      "state": "NC",
      "title": "Sen.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "C000560",
      "district": null,
      "name": "Coburn, Tom",
      "original_cosponsor": false,
      "sponsored_at": "2012-03-22",
      "state": "OK",
      "title": "Sen.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2011-10-13",
  "number": "1700",
  "official_title": "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to device review determinations and conflicts of interest, and for other purposes.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Medical Device Regulatory Improvement Act",
  "sponsor": {
    "bioguide_id": "K000367",
    "district": null,
    "name": "Klobuchar, Amy",
    "state": "MN",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2011-10-13",
  "subjects": [
    "Advisory bodies",
    "Congressional oversight",
    "Department of Health and Human Services",
    "Drug safety, medical device, and laboratory regulation",
    "Food and Drug Administration (FDA)",
    "Government ethics and transparency, public corruption",
    "Government studies and investigations",
    "Health",
    "Health technology, devices, supplies"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2011-10-13",
    "date": "2012-01-27T23:20:51Z",
    "text": "Medical Device Regulatory Improvement Act - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services (HHS), in determining the least burdensome appropriate means of evaluating device effectiveness, to: (1) not request information unrelated or irrelevant to demonstration of reasonable assurance of device safety and effectiveness; (2) consider alternative approaches to evaluating device safety and effectiveness; (3) use all reasonable mechanisms to lessen review times and render regulatory decisions; (4) determine whether pre-clinical data can meet the statutory threshold for approval; and (5) utilize, whenever practicable, alternatives to randomized, controlled clinical trials if clinical data are needed.\n\nRequires the Secretary, in determining the least burdensome means of determining substantial equivalence, to: (1) focus on whether the device has the same intended use as the predicate device and is as safe and effective as a legally marketed device, (2) not request or accept information unrelated or irrelevant to the substantial equivalence evaluation, (3) review the labeling of the device to assess the intended use of the device and not evaluate issues that do not present a major impact on the intended use as set forth in the labeling, (4) consider alternative approaches to evaluating substantial equivalence, and (5) use all reasonable mechanisms to lessen review times and render regulatory decisions.\n\nRepeals conflict-of-interest provisions that are specific to the Food and Drug Administration (FDA) and provides for the continued applicability of conflict-of-interest provisions otherwise applicable to advisory committees, federal employees, and special government employees.\n\nRequires the Secretary to contract with an eligible entity for a review of the management and regulatory processes at the Center for Devices and Radiological Health."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Medical Device Regulatory Improvement Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to device review determinations and conflicts of interest, and for other purposes.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Medical Device Regulatory Improvement Act",
      "type": "short"
    }
  ],
  "updated_at": "2023-01-11T13:21:59Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/112/s/BILLSTATUS-112s1700.xml"
}